Dose of Vestibular Rehabilitation for Vestibular Hypofunction

Launched by GEORGE WASHINGTON UNIVERSITY · Apr 14, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how virtual reality (VR) can help improve symptoms for people with vestibular disorders, which often cause dizziness. The researchers want to find out the right amount of exercise needed to help relieve these symptoms, and how VR exercises compare to standard physical therapy. They will also look at how people with vestibular disorders perform these exercises compared to healthy individuals who don’t have dizziness issues. By using a VR device, they can create a more comfortable exercise environment that minimizes distractions, making it easier for participants to engage in their workouts.

To be eligible for the study, participants should have known or suspected issues with balance and dizziness, or be healthy volunteers without any dizziness to act as a comparison group. However, certain conditions exclude individuals from participating, such as having a recent concussion, a history of stroke, or certain serious health problems. Participants can expect to engage in exercises while wearing a VR headset, and their progress will be monitored closely. Overall, this study aims to better understand how to tailor exercise programs for those suffering from vestibular disorders, potentially leading to more effective treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Known or suspected vestibular dysfunction
• • Healthy volunteers without dizziness to serve as healthy control subjects
• Exclusion Criteria:
• • Previous cerebrovacular accident (stroke)
• • Reported neurologic or oculuomotor disease
• • Taking of medications that affect the vestibular or oculomotor system.
• • Current symptoms of benign paroxysmal positional hypofunction
• • Concussion occuring less than 7 days prior to enrollment in this study
• • Currently pregnant, or plan to become pregnant during the timeline of the study
• • Chronic kidney disease
• • COPD
• • Known coronary artery disease or cardiomyopathy
• • immunocompromised state from a solid organ transplant
• • Severe Obesity as defined by BMI of greater than or equal to 40 kg/m2
• • Sickle cell disease